DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
TEBENTAFUSP-TEBN
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
TEBENTAFUSP-TEBN
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CHLORAMPHENICOL; HYDROCORTISONE ACETATE
4
Combination
Approved
OTHER
OPHTHALMIC
Unknown
Unknown
CHLORAMPHENICOL; HYDROCORTISONE ACETATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CYCLOPENTOLATE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE
4
Combination
Approved
OTHER
OPHTHALMIC
Unknown
Unknown
CYCLOPENTOLATE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
POTASSIUM SODIUM TARTRATE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
POTASSIUM SODIUM TARTRATE
×
Maximum Phase:
4
First Approval:
None
UNII:
QH257BPV3J
Molecule Type:
Small molecule
Molecular Formula:
C4H12KNaO10
Molecular Weight:
282.22
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
FERROUS CITRATE, FE-59
4
Small molecule
Approved
OTHER
INJECTION
Unknown
Unknown
FERROUS CITRATE, FE-59
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
POLYVINYL ALCOHOL
4
Small molecule
Approved
Unknown
Unknown
Fatigue
Unknown
POLYVINYL ALCOHOL
×
Maximum Phase:
4
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GLYCOPYRROLATE ; INDACATEROL MALEATE
4
Combination
Approved
Unknown
INHALATION
Unknown
Unknown
GLYCOPYRROLATE ; INDACATEROL MALEATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ZOLEDRONATE
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
ZOLEDRONATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FOSTIMON
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
FOSTIMON
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CONESTAT ALFA
4
Protein
Unknown
Unknown
Unknown
Acute Kidney Injury; Genetic Diseases, Inborn; Graft vs Host Disease; Non-ST Elevated Myocardial Infarction; Severe Acute Respiratory Syndrome; Angioedemas, Hereditary
Unknown
CONESTAT ALFA
×
Maximum Phase:
4
First Approval:
None
UNII:
5QS67N4551
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
OnabotulinumtoxinA
4
Unknown
Approved
DERMATOLOGY; MUSCULOSKELETAL; OTHER
SINGLE-USE
Unknown
Synaptosomal-associated protein 25 inhibitor
OnabotulinumtoxinA
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PROGLUMIDE
4
Small molecule
Approved
Unknown
Unknown
Liver Cirrhosis; Non-alcoholic Fatty Liver Disease; Gastroesophageal Reflux; Peptic Ulcer
Cholecystokinin receptor antagonist
PROGLUMIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
EPL8W5565D
Molecule Type:
Small molecule
Molecular Formula:
C18H26N2O4
Molecular Weight:
334.42
AlogP:
2.3
PSA:
86.71
HBD:
2.0
HBA:
#RotB:
10.0
Source:
UREA, C-14
4
Small molecule
Approved
OTHER
ORAL
Unknown
Unknown
UREA, C-14
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ISOPROTERENOL HYDROCHLORIDE; PHENYLEPHRINE BITARTRATE
4
Combination
Approved
OTHER
INHALATION
Unknown
Unknown
ISOPROTERENOL HYDROCHLORIDE; PHENYLEPHRINE BITARTRATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CITRIC ACID; GLUCONOLACTONE; MAGNESIUM CARBONATE
4
Combination
Approved
OTHER
IRRIGATION
Unknown
Unknown
CITRIC ACID; GLUCONOLACTONE; MAGNESIUM CARBONATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CARBOXYMETHYLCELLULOSE
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
CARBOXYMETHYLCELLULOSE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
COD LIVER OIL
4
Small molecule
Approved
Unknown
Unknown
Unknown
Supplement
COD LIVER OIL
×
Maximum Phase:
4
First Approval:
None
UNII:
BBL281NWFG
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AMINO ACIDS; CALCIUM ACETATE; GLYCERIN; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
AMINO ACIDS; CALCIUM ACETATE; GLYCERIN; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
INJECTAFER
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
INJECTAFER
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GLUCOMANNAN
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
GLUCOMANNAN
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GENTAMICIN SULFATE; PREDNISOLONE ACETATE
4
Combination
Approved
OTHER
OPHTHALMIC
Unknown
Unknown
GENTAMICIN SULFATE; PREDNISOLONE ACETATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FLUNITRAZEPAM
4
Small molecule
Approved
Unknown
Unknown
Unknown
GABA-A receptor; anion channel positive allosteric modulator
FLUNITRAZEPAM
×
Maximum Phase:
4
First Approval:
None
UNII:
620X0222FQ
Molecule Type:
Small molecule
Molecular Formula:
C16H12FN3O3
Molecular Weight:
313.29
AlogP:
2.55
PSA:
75.81
HBD:
0.0
HBA:
#RotB:
2.0
Source:
LOTEPREDNOL ETABONATE; TOBRAMYCIN
4
Combination
Approved
OTHER
OPHTHALMIC
Unknown
Unknown
LOTEPREDNOL ETABONATE; TOBRAMYCIN
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TRASTUZUMAB-QYYP
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
TRASTUZUMAB-QYYP
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ALENDRONATE SODIUM; CHOLECALCIFEROL
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
ALENDRONATE SODIUM; CHOLECALCIFEROL
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NORETHINDRONE ACETATE;ETHINYL ESTRADIOL;ETHINYL ESTRADIOL;FERROUS FUMARATE
4
Combination
Approved
Unknown
ORAL
Unknown
Unknown
NORETHINDRONE ACETATE;ETHINYL ESTRADIOL;ETHINYL ESTRADIOL;FERROUS FUMARATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
OZONE
4
Small molecule
Approved
Unknown
Unknown
Coronary Disease; Cystitis, Interstitial; Diabetes Mellitus; Severe Acute Respiratory Syndrome
Unknown
OZONE
×
Maximum Phase:
4
First Approval:
None
UNII:
66H7ZZK23N
Molecule Type:
Small molecule
Molecular Formula:
O3
Molecular Weight:
48.0
AlogP:
-1.12
PSA:
51.43
HBD:
0.0
HBA:
#RotB:
0.0
Source:
COLESTIPOL
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
COLESTIPOL
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GLYCYRRHETINIC ACID
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
GLYCYRRHETINIC ACID
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PHENOTHRIN
4
Small molecule
Approved
Unknown
Unknown
Ectoparasitic Infestations
Unknown
PHENOTHRIN
×
Maximum Phase:
4
First Approval:
None
UNII:
707484X33X
Molecule Type:
Small molecule
Molecular Formula:
C23H26O3
Molecular Weight:
350.46
AlogP:
5.76
PSA:
35.53
HBD:
0.0
HBA:
#RotB:
6.0
Source:
ETHINYL ESTRADIOL; FERROUS FUMARATE; NORETHINDRONE
4
Combination
Approved
OTHER
ORAL-28
Unknown
Unknown
ETHINYL ESTRADIOL; FERROUS FUMARATE; NORETHINDRONE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR DISOPROXIL FUMARATE
4
Combination
Approved
IMMUNE SYSTEM
ORAL
Unknown
Unknown
EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR DISOPROXIL FUMARATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NICORANDIL
4
Small molecule
Approved
Unknown
Unknown
Dementia; Premature Birth; Radiation Pneumonitis; Myocardial Infarction; Severe Acute Respiratory Syndrome; Cardiovascular Diseases
Unknown
NICORANDIL
×
Maximum Phase:
4
First Approval:
None
UNII:
260456HAM0
Molecule Type:
Small molecule
Molecular Formula:
C8H9N3O4
Molecular Weight:
211.18
AlogP:
0.02
PSA:
94.36
HBD:
1.0
HBA:
#RotB:
5.0
Source:
ACEFYLLINE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
ACEFYLLINE
×
Maximum Phase:
4
First Approval:
None
UNII:
M494UE2YEP
Molecule Type:
Small molecule
Molecular Formula:
C9H10N4O4
Molecular Weight:
238.2
AlogP:
-1.48
PSA:
99.12
HBD:
1.0
HBA:
#RotB:
2.0
Source:
1
2
…
268
269
270
271
272
273
274
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA